Healthcare & Life Sciences
Avere Therapeutics
About
Avere Therapeutics is a biotechnology company developing oral therapies for the treatment of IL-23-driven inflammatory diseases.
Explore Avere Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.